Skip to content

Clinical trials

Peripheral Vascular Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Vascular Diseases Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20121
20152
20162
20171
20193
20201
20213
20221
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status12
Completed5
Recruiting3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chengdu University of Traditional Chinese Medicine7
Beijing Northland Biotech. Co., Ltd.3
Jie Shen3
Acotec Scientific Co., Ltd1
Allife Medical Science and Technology Co., Ltd.1
Boston Scientific Corporation1
Cordis US Corp.1
Hangzhou Wei Qiang Medical Technology Co., Ltd.1
Second Affiliated Hospital of Soochow University1
Second Affiliated Hospital, Zhejiang University, School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Vascular Diseases22
Ischemia6
Chronic Limb-Threatening Ischemia4
Ulcer4
Arterial Occlusive Diseases3
Diabetic Foot3
Varicose Veins3
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Intermittent Claudication1

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.